Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

Price is unknown


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. The company also retails health and beauty products to consumers; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and procedures. In addition, its services include wholesale product delivery, retail services, marketing programs, and business advisory services. The company markets its products and services under the Soul Pattinson Chemist, Pharmacist Advice, Club Premium, and Pharmacy Best Buys brand names, as well as through 488 Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores. Australian Pharmaceutical Industries Limited was founded in 1910 and is based in Camberwell, Australia.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Aug '09 Aug '10 Aug '11 Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18 Aug '19
Equity (BVPS) 1.43
1.21
1.14
1.16
1.18
0.95
1.01
1.06
1.12
1.14
1.03
growth rate -15.4% -5.8% 1.8% 1.7% -19.5% 6.3% 5.0% 5.7% 1.8% -9.7%
Earnings BIT 27.18
35.67
-29.98
43.43
55.63
63.94
73.57
86.20
83.32
73.51
84.56
growth rate 31.2% -100.0% 100.0% 28.1% 14.9% 15.1% 17.2% -3.3% -11.8% 15.0%
Avg.PE 10.42
8.33
-7.80
6.05
9.75
-0.97
19.41
21.52
14.49
17.99
12.57
growth rate -20.1% -100.0% 100.0% 61.2% -100.0% 100.0% 10.9% -32.7% 24.2% -30.1%
ROA 1.82
1.79
-1.62
2.19
1.77
-6.81
3.28
3.70
3.61
3.25
3.48
growth rate -1.7% -100.0% 100.0% -19.2% -100.0% 100.0% 12.8% -2.4% -10.0% 7.1%
ROE 4.36
4.42
-4.07
5.39
4.22
-17.05
8.75
9.92
9.60
9.04
10.72
growth rate 1.4% -100.0% 100.0% -21.7% -100.0% 100.0% 13.4% -3.2% -5.8% 18.6%
ROIC 7.77
5.09
-0.56
4.94
3.80
-11.78
8.21
10.62
9.69
8.48
9.82
growth rate -34.5% -100.0% 100.0% -23.1% -100.0% 100.0% 29.4% -8.8% -12.5% 15.8%
Cur. Ratio 0.93
1.20
1.15
1.39
1.39
1.36
1.28
1.34
1.32
1.33
1.24
growth rate 29.0% -4.2% 20.9% 0.0% -2.2% -5.9% 4.7% -1.5% 0.8% -6.8%
Quick Ratio 0.43
0.83
0.76
0.86
0.84
0.86
0.80
0.85
0.85
0.85
0.78
growth rate 93.0% -8.4% 13.2% -2.3% 2.4% -7.0% 6.3% 0.0% 0.0% -8.2%
Leverage 2.41
2.51
2.50
2.42
2.36
2.68
2.66
2.70
2.62
2.95
3.21
growth rate 4.2% -0.4% -3.2% -2.5% 13.6% -0.8% 1.5% -3.0% 12.6% 8.8%
Balance Sheet Aug '09 Aug '10 Aug '11 Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18 Aug '19
Acct.Receivable 147.50
73.80
590.00
581.00
560.45
565.81
594.76
689.70
681.62
654.66
657.93
growth rate -50.0% 699.5% -1.5% -3.5% 1.0% 5.1% 16.0% -1.2% -4.0% 0.5%
Acct.Payable 530.00
529.00
561.83
566.66
609.42
748.75
804.47
778.00
790.27
growth rate -0.2% 6.2% 0.9% 7.6% 22.9% 7.4% -3.3% 1.6%
Cur.Assets 550.10
1,051.90
945.00
921.00
918.97
931.82
993.81
1,128.97
1,120.74
1,085.83
1,101.37
growth rate 91.2% -10.2% -2.5% -0.2% 1.4% 6.7% 13.6% -0.7% -3.1% 1.4%
Total Assets 1,047.20
1,484.90
1,391.00
1,373.00
1,375.52
1,289.07
1,342.55
1,449.71
1,451.08
1,521.34
1,665.21
growth rate 41.8% -6.3% -1.3% 0.2% -6.3% 4.2% 8.0% 0.1% 4.8% 9.5%
Cash 5.90
29.40
35.00
20.00
22.58
23.53
28.05
25.49
39.78
35.95
30.18
growth rate 398.3% 19.1% -42.9% 12.9% 4.2% 19.2% -9.1% 56.1% -9.6% -16.0%
Inventory 292.90
322.10
320.00
321.00
335.94
342.48
364.21
413.78
399.34
395.22
413.26
growth rate 10.0% -0.7% 0.3% 4.7% 2.0% 6.3% 13.6% -3.5% -1.0% 4.6%
Cur.Liabilities 591.20
876.40
817.00
671.00
661.08
686.83
777.72
845.63
851.03
817.67
887.48
growth rate 48.2% -6.8% -17.9% -1.5% 3.9% 13.2% 8.7% 0.6% -3.9% 8.5%
Liabilities 612.70
893.80
837.00
805.00
791.83
808.33
837.15
913.01
896.83
1,010.64
1,142.91
growth rate 45.9% -6.4% -3.8% -1.6% 2.1% 3.6% 9.1% -1.8% 12.7% 13.1%
LT Debt 6.10
0.50
0.50
121.00
114.74
99.32
37.38
45.99
28.64
88.51
169.45
growth rate -91.8% 0.0% 24,100.0% -5.2% -13.4% -62.4% 23.0% -37.7% 209.0% 91.4%
Equity 434.50
591.20
554.40
568.30
584.10
480.74
505.40
536.70
554.25
508.78
518.92
growth rate 36.1% -6.2% 2.5% 2.8% -17.7% 5.1% 6.2% 3.3% -8.2% 2.0%
Common Shares 304.00
441.00
488.00
488.00
488.00
488.00
496.00
492.00
494.00
495.00
496.00
growth rate 45.1% 10.7% 0.0% 0.0% 0.0% 1.6% -0.8% 0.4% 0.2% 0.2%
Cash Flow Statement Aug '09 Aug '10 Aug '11 Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18 Aug '19
Capital Expenditures 34.70
33.60
18.00
20.00
18.88
10.86
8.03
14.42
28.29
25.70
35.70
growth rate -3.2% -46.4% 11.1% -5.6% -42.5% -26.0% 79.5% 96.2% -9.2% 38.9%
Cash Dividends 2.60
10.00
12.20
14.60
14.60
15.86
19.53
24.43
34.29
34.46
38.17
growth rate 284.6% 22.0% 19.7% 0.0% 8.7% 23.1% 25.1% 40.3% 0.5% 10.8%
Cash From OA 11.60
43.40
45.00
48.00
66.60
64.19
80.06
82.86
95.48
53.65
11.61
growth rate 274.1% 3.7% 6.7% 38.8% -3.6% 24.7% 3.5% 15.2% -43.8% -78.4%
FCF per Share -0.11
0.02
0.06
0.06
0.10
0.05
0.11
-0.10
0.24
0.12
-0.12
growth rate 100.0% 200.0% 0.0% 66.7% -50.0% 120.0% -100.0% 100.0% -50.0% -100.0%
FCF -32.00
9.00
30.00
28.00
42.00
34.00
49.00
63.00
67.00
28.00
-24.00
growth rate 100.0% 233.3% -6.7% 50.0% -19.1% 44.1% 28.6% 6.4% -58.2% -100.0%
Income Statement Aug '09 Aug '10 Aug '11 Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18 Aug '19
Sales 3,549.70
3,713.30
3,426.00
3,199.00
3,166.37
3,345.95
3,457.40
3,839.99
4,061.20
4,026.30
4,010.73
growth rate 4.6% -7.7% -6.6% -1.0% 5.7% 3.3% 11.1% 5.8% -0.9% -0.4%
Op.Income 42.70
45.90
-23.00
30.00
55.63
63.94
73.57
86.20
83.32
73.51
84.56
growth rate 7.5% -100.0% 100.0% 85.4% 14.9% 15.1% 17.2% -3.3% -11.8% 15.0%
IBT 27.20
35.70
-30.00
43.40
35.00
-85.04
59.46
68.91
76.41
70.03
73.74
growth rate 31.3% -100.0% 100.0% -19.4% -100.0% 100.0% 15.9% 10.9% -8.4% 5.3%
Net Income 18.60
22.60
-23.00
30.00
24.29
-90.77
43.13
51.67
52.37
48.06
55.11
growth rate 21.5% -100.0% 100.0% -19.0% -100.0% 100.0% 19.8% 1.4% -8.2% 14.7%
EPS 0.06
0.05
-0.05
0.06
0.05
-0.18
0.08
0.10
0.10
0.10
0.11
growth rate -16.7% -100.0% 100.0% -16.7% -100.0% 100.0% 25.0% 0.0% 0.0% 10.0%
Gross Profit 368.90
375.10
370.00
389.00
404.25
431.80
453.79
477.93
493.63
496.71
518.31
growth rate 1.7% -1.4% 5.1% 3.9% 6.8% 5.1% 5.3% 3.3% 0.6% 4.4%

Quarterly Statements

Item Name Feb '19 May '19 Aug '19 Nov '19 Feb '20
Earnings BIT 19.96
22.32
22.32
18.83
18.83
growth rate 11.8% 0.0% -15.6% 0.0%
Balance Sheet Feb '19 May '19 Aug '19 Nov '19 Feb '20
Acct.Receivable 614.16
657.93
657.93
540.39
540.39
growth rate 7.1% 0.0% -17.9% 0.0%
Acct.Payable 642.11
790.27
790.27
731.66
731.66
growth rate 23.1% 0.0% -7.4% 0.0%
Cur.Assets 1,032.10
1,101.37
1,101.37
1,018.13
1,018.13
growth rate 6.7% 0.0% -7.6% 0.0%
Total Assets 1,568.75
1,665.21
1,665.21
1,658.97
1,658.97
growth rate 6.2% 0.0% -0.4% 0.0%
Cash 14.96
30.18
30.18
64.91
64.91
growth rate 101.8% 0.0% 115.1% 0.0%
Inventory 402.99
413.26
413.26
412.84
412.84
growth rate 2.6% 0.0% -0.1% 0.0%
Cur.Liabilities 734.15
887.48
887.48
809.67
809.67
growth rate 20.9% 0.0% -8.8% 0.0%
Liabilities 1,059.25
1,142.91
1,142.91
1,149.84
1,149.84
growth rate 7.9% 0.0% 0.6% 0.0%
LT Debt 221.56
169.45
169.45
140.82
140.82
growth rate -23.5% 0.0% -16.9% 0.0%
Equity 505.76
518.92
518.92
504.98
504.98
growth rate 2.6% 0.0% -2.7% 0.0%
Common Shares 566.46
566.46
566.46
566.46
566.46
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Feb '19 May '19 Aug '19 Nov '19 Feb '20
Capital Expenditures 6.62
11.23
11.23
10.68
10.68
growth rate 69.6% 0.0% -4.9% 0.0%
Cash Dividends 9.85
9.24
9.24
9.85
9.85
growth rate -6.3% 0.0% 6.7% 0.0%
Cash From OA -44.69
50.49
50.49
55.74
55.74
growth rate 100.0% 0.0% 10.4% 0.0%
FCF -51.31
39.26
39.26
45.06
45.06
growth rate 100.0% 0.0% 14.8% 0.0%
Income Statement Feb '19 May '19 Aug '19 Nov '19 Feb '20
Sales 988.55
1,016.81
1,016.81
1,016.53
1,016.53
growth rate 2.9% 0.0% 0.0% 0.0%
Op.Income 19.96
22.32
22.32
18.83
18.83
growth rate 11.8% 0.0% -15.6% 0.0%
IBT 18.17
18.70
18.70
14.53
14.53
growth rate 2.9% 0.0% -22.3% 0.0%
Net Income 12.12
15.43
15.43
10.88
10.88
growth rate 27.4% 0.0% -29.5% 0.0%
Gross Profit 132.95
126.20
126.20
127.61
127.61
growth rate -5.1% 0.0% 1.1% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.07)

YOY Growth Grade:

E (18.40)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 10.14 10.14 8.96
EPS / Growth 22.0% 0.11 5.3%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 3.1% 3.1%
Future PE 2.00 8.46 8.46
Future EPS 0.12 0.14 0.14
Value Price
MOS %
0.06
0.30
0.30
MOS Price 0.03 0.15 0.15
IRT

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.